Document is current

Any future updates will be listed below

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-947

Published Online: 2014-12-13

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark